Related Experiment Video
Updated: Apr 26, 2026

07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
14.5K
Mimotope-based prediction of B-cell epitopes
Jian Huang1, Bifang He, Peng Zhou
1Center of Bioinformatics (COBI), Key Laboratory for NeuroInformation of Ministry of Education, University of Electronic Science and Technology of China, Room 341, Yifu Building, Shahe Campus, No. 4, Section 2, North Jianshe Road, Chengdu, 610054, China, hj@uestc.edu.cn.
Methods in Molecular Biology (Clifton, N.J.)
|July 23, 2014
Summary
Mimotopes from phage display are useful for predicting B-cell epitopes. This work details methods for data retrieval, cleaning, and decoding to improve prediction accuracy.
Area of Science:
- Immunoinformatics
- Peptide Chemistry
- Biotechnology
Background:
- Mimotopes, peptides mimicking epitopes, are generated using phage display technology.
- Phage display libraries can yield both mimotopes and target-unrelated peptides, complicating analysis.
- Predicting B-cell epitopes from mimotope data is a viable strategy.
Purpose of the Study:
- To summarize mimotope-based B-cell epitope prediction strategies.
- To provide protocols and tips for handling phage display data.
- To improve the precision of B-cell epitope prediction.
Main Methods:
- Phage display for generating random peptide libraries.
- Panning libraries against monoclonal antibodies or sera to select mimotopes.
- Data retrieval, cleaning, and decoding protocols for phage display outputs.
Main Results:
- Mimotope-based prediction offers a promising approach for B-cell epitope identification.
- Effective data processing is crucial for accurate epitope prediction.
- Strategies for handling target-unrelated peptides are essential.
Conclusions:
- Phage display is a powerful tool for discovering mimotopes and predicting B-cell epitopes.
- Careful data management enhances the reliability of mimotope-based epitope prediction.
- This chapter provides practical guidance for researchers in the field.
Related Concept Videos
Hybridoma Technology
13.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.1K
Cross-reactivity
28.7K
Overview
28.7K

